Image

Global Orthostatic Hypotension Drugs Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Orthostatic Hypotension Drugs Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Orthostatic Hypotension Drugs Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 744.93 USD Million
Diagram Market Size (Forecast Year) USD 1,313.81 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Orthostatic Hypotension Drugs Market, By Diagnostic Test Type (ECG, Blood Tests, Stress Test, Other), Drug Type (Fludrocortisone, Midodrine Hydrochloride, Droxidopa, Pyridostigmine, Indomethacin, Caffeine, Epoetin, Oxilofrine Potassium Chloride, NSAIDs (Nonsteroidal anti-Inflammatory Drugs)), End user (Hospitals, ASCs and Clinics, Others) – Industry Trends and Forecast to 2030.

Orthostatic Hypotension Drugs Market

Orthostatic Hypotension Drugs Market Analysis and Size

Orthostatic hypotension is widespread in people 65 and older. Physicians should keep a high index of suspicion when giving medications that are frequently known to induce this illness, especially in the elderly, because orthostatic hypotension is easily detectable by methods that are accessible to all doctors. The screening and monitoring of orthostatic hypotension should be implemented as a regular precaution in suitable patients due to the prevalent medical disorders requiring these medications. 2/3 of older individuals have hypertension. Orthostatic hypotension is a rare side effect of most medications used to treat hypertension; nevertheless, it is more frequent with alpha 1-blockers (initial dosage), adrenergic blockers, and medications with central actions.

Data Bridge Market Research analyses that the orthostatic hypotension drugs market, which was USD 744.93 million in 2022, is expected to reach USD 1,313.81 million by 2030, at a CAGR of 7.35% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Orthostatic Hypotension Drugs Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Diagnostic Test Type (ECG, Blood Tests, Stress Test, Other), Drug Type (Fludrocortisone, Midodrine Hydrochloride, Droxidopa, Pyridostigmine, Indomethacin, Caffeine, Epoetin, Oxilofrine Potassium Chloride, NSAIDs (Nonsteroidal anti-Inflammatory Drugs)), End user (Hospitals, ASCs and Clinics, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Mylan N.V. (U.S.), Upsher-Smith Laboratories, LLC (U.S.), Chelsea Therapeutics International, Ltd (U.S.), Amgen Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Apotex Inc (Canada), Pfizer Inc. (U.S.), Novartis AG (Germany), H. Lundbeck A/S  (Denmark) and Amneal Pharmaceuticals LLC (U.S.)

Market Opportunities

  • Increasing clinical trials and FDA approvals on the development of new drugs for orthostatic hypotension

Market Definition

Orthostatic hypotension, also known as postural hypotension, is a condition characterized by dizziness caused by low blood pressure. It is common when a person stands up from a long sitting and experiences dizziness. Dehydration, heart, endocrine, and nervous system disorders can all contribute to it. It has also been discovered that elderly nursing home residents are more susceptible to O.H. than those living in the community. When a person has orthostatic hypotension, their diastolic blood pressure drops by at least 10 mm Hg, and their systolic blood pressure drops by at least 20 mm Hg.

Global Orthostatic Hypotension Drugs Market Dynamics

Drivers

  • Increasing prevalence of chronic diseases

The risk of O.H. is rising due to the global rise in diabetes, cardiovascular illness, and neurodegenerative diseases. It is linked to a dysfunction of the autonomic nervous system. Dehydration is another prevalent illness that raises the risk of O.H. and harms the nerves in humans. The global market for drugs to treat orthostatic hypotension is expected to grow at a CAGR of nearly 8% during the forecast period due to the rise in the prevalence of chronic diseases linked to a high risk of O.H.

  • The rise in the use of combination therapy in O.H. treatment

O.H. is a persistent, disabling condition that can be challenging to manage in certain patients. Orthostatic stress varies throughout the day; therefore, treating O.H. patients with a single medication may not be sufficient. As a result, the use of combination therapy in the treatment of O.H. is receiving more attention. This development is anticipated to boost market expansion.

Opportunities

  • Increasing demand for diagnosis tests

A stress test is performed during exercise, such as treadmill walking. People who cannot exercise may be given medication to force their hearts to work harder. Electrocardiography, echocardiography, or other tests are then used to monitor the heart. Thus, these tests are commonly used to diagnose the patient's condition for the fastest recovery, and thus, it creates many opportunities for the drug development processes.

Restraints/Challenges

  • The lack of clinical evidence

The adoption of non-pharmacological treatment options such as first-line therapy, low diagnosis rates, a lack of clinical evidence, and unfavorable safety profiles of O.H. drugs, among other factors, could impede the growth of the orthostatic hypotension drugs market during the forecast period. The drugs that can increase the risk of orthostatic hypotension include narcotics, some antidepressants, some antipsychotics, muscle relaxants, and drugs used to treat erectile dysfunction and Parkinson's disease.

This orthostatic hypotension drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the orthostatic hypotension drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Orthostatic Hypotension Drugs Market Scope

The orthostatic hypotension drugs market is segmented on the basis of diagnosis test type, drug type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnostic Test Type

  • ECG
  • Blood Test
  • Stress Test
  • Other

 Drug Type

  • Fludrocortisone
  • Midodrine Hydrochloride
  • Droxidopa
  • Pyridostigmine
  • Indomethacin
  • Caffeine
  • Epoetin
  • Oxilofrine Potassium Chloride
  • NSAIDs (Nonsteroidal anti-Inflammatory Drugs)

 End user

  • Hospitals
  • ASCs
  • Clinics
  • Others

Orthostatic Hypotension Drugs Market Regional Analysis/Insights

The orthostatic hypotension drugs market is analysed and market size insights and trends are provided by country, diagnosis test type, drug type and end-user as referenced above.

The countries covered in the orthostatic hypotension drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the orthostatic hypotension drugs market due to the adoption of technologically advanced tools to improve healthcare infrastructure to reduce patient waiting time and maximize bed utilization in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030, owing to the growing awareness of drugs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Orthostatic Hypotension Drugs Market Share Analysis

The orthostatic hypotension drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to orthostatic hypotension drugs market.

Some of the major players operating in the orthostatic hypotension drugs market are:

  • Mylan N.V. (U.S.)
  • Upsher-Smith Laboratories, LLC (U.S.)
  • Chelsea Therapeutics International, Ltd (U.S.)
  • Amgen Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Apotex Inc (Canada)
  • Pfizer Inc. (U.S.)
  • Novartis AG (Germany)
  • H. Lundbeck A/S (Denmark)
  • Amneal Pharmaceuticals LLC (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Orthostatic Hypotension Drugs Market will be worth USD 1,313.81 million in the forecast period by 2030,
The Orthostatic Hypotension Drugs Market growth rate is 7.35% during the forecast period.
The rise in the use of combination therapy in O.H. treatment & Increasing prevalence of chronic diseases are the growth drivers of the Orthostatic Hypotension Drugs Market.
The diagnosis test type, drug type and end-user are the factors on which the Orthostatic Hypotension Drugs Market research is based.
Major companies in the Orthostatic Hypotension Drugs Market are Mylan N.V. (U.S.), Upsher-Smith Laboratories, LLC (U.S.), Chelsea Therapeutics International, Ltd (U.S.), Amgen Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Apotex Inc (Canada), Pfizer Inc. (U.S.), Novartis AG (Germany), H. Lundbeck A/S (Denmark) and Amneal Pharmaceuticals LLC (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials